Sugentech Inc - Asset Resilience Ratio
Sugentech Inc (253840) has an Asset Resilience Ratio of 25.25% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 253840 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Sugentech Inc's Asset Resilience Ratio has changed over time. See 253840 book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Sugentech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Sugentech Inc worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩24.80 Billion | 25.25% |
| Total Liquid Assets | ₩24.80 Billion | 25.25% |
Asset Resilience Insights
- Very High Liquidity: Sugentech Inc maintains exceptional liquid asset reserves at 25.25% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Sugentech Inc Industry Peers by Asset Resilience Ratio
Compare Sugentech Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Sugentech Inc (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Sugentech Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.25% | ₩24.80 Billion ≈ $16.81 Million |
₩98.21 Billion ≈ $66.56 Million |
-24.49pp |
| 2024-12-31 | 49.75% | ₩53.55 Billion ≈ $36.29 Million |
₩107.64 Billion ≈ $72.95 Million |
-0.32pp |
| 2023-12-31 | 50.07% | ₩66.68 Billion ≈ $45.19 Million |
₩133.19 Billion ≈ $90.26 Million |
-13.34pp |
| 2022-12-31 | 63.40% | ₩109.87 Billion ≈ $74.46 Million |
₩173.30 Billion ≈ $117.44 Million |
-6.24pp |
| 2021-12-31 | 69.64% | ₩108.34 Billion ≈ $73.42 Million |
₩155.56 Billion ≈ $105.42 Million |
+20.59pp |
| 2020-12-31 | 49.06% | ₩35.54 Billion ≈ $24.09 Million |
₩72.46 Billion ≈ $49.10 Million |
-15.92pp |
| 2019-12-31 | 64.97% | ₩29.51 Billion ≈ $20.00 Million |
₩45.42 Billion ≈ $30.78 Million |
+29.53pp |
| 2018-12-31 | 35.44% | ₩8.64 Billion ≈ $5.85 Million |
₩24.37 Billion ≈ $16.52 Million |
+17.02pp |
| 2017-12-31 | 18.42% | ₩3.37 Billion ≈ $2.28 Million |
₩18.28 Billion ≈ $12.39 Million |
-- |
About Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more